Related Experiment Videos

Tight heparin regimen for haemodialysis in children

S Ozen1, U Saatçi, A Bakkaloğlu

  • 1Department of Paediatric Nephrology, Hacettepe University Children's Hospital, Ankara, Turkey.

Insights

This study determined the lowest effective heparin dose for dialysis in children with bleeding risks. A low-dose continuous heparinization proved safe and cost-effective for completing dialysis procedures.

Area of Science:

  • Nephrology
  • Hematology
  • Pediatrics

Background:

  • Patients undergoing dialysis often require anticoagulation.
  • Managing anticoagulation in patients with bleeding risks presents significant challenges.
  • Uremic patients are particularly susceptible to hemorrhage during anticoagulation therapy.

Purpose of the Study:

  • To define the minimum effective dose of heparin for anticoagulation during dialysis in pediatric patients with elevated bleeding risks.
  • To evaluate the safety and efficacy of a low-dose continuous heparinization protocol.

Main Methods:

  • A prospective study involving seven pediatric patients with uremia and bleeding risks.
  • Continuous heparin infusion at a dose of 15 IU/kg body weight per hour was administered.
  • Prothrombin time (PTT) and Lee-White clotting time were monitored.

Main Results:

  • Fifty-one dialysis procedures were successfully completed using the defined low-dose heparin regimen.
  • Anticoagulation levels, as measured by PTT and Lee-White clotting time, remained within the desired therapeutic range.
  • No hemorrhagic complications were observed in any of the patients during the study period.

Conclusions:

  • Low-dose continuous heparinization is a safe and effective anticoagulation strategy for pediatric patients with uremia and bleeding risks undergoing dialysis.
  • This technique offers a cost-effective approach to anticoagulation in this vulnerable patient population.
  • Further research may explore optimal dosing in diverse pediatric populations.

Related Concept Videos